Thyrocare Technologies is trading -0.61% lower at Rs 717.50 as compared to its last closing price. Thyrocare Technologies has been trading in the price range of 725.20 & 695.25. Thyrocare Technologies has given -20.66% in this year & -7.71% in the last 5 days. Thyrocare Technologies has TTM P/E ratio 54.98 as compared to the sector P/E of 23.47.There are 1 analysts who have initiated coverage on Thyrocare Technologies. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 19.11 Crores in its last quarter.Listed peers of Thyrocare Technologies include Healthcare Global Enterprises (-0.08%), Kovai Medical Centre and Hospital (-1.44%), Thyrocare Technologies (-0.61%).The Mutual Fund holding in Thyrocare Technologies was at 12.75% in 31 Dec 2024. The MF holding has decreased from the last quarter. The FII holding in Thyrocare Technologies was at 2.77% in 31 Dec 2024. The FII holding has increased from the last quarter.
Updated on Feb 17, 2025, 11:59 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Healthcare Global Enterprises | Neutral | 489.15 | -0.08 | 6,787.71 | 150.11 | 8.26 | - | 126.44 |
Kovai Medical Centre and Hospital | Bullish | 5,900.00 | -1.44 | 6,455.93 | 36.39 | 7.37 | 0.17 | 32.25 |
Thyrocare Technologies | Bearish | 717.50 | -0.61 | 3,801.77 | 53.70 | 7.27 | 2.49 | 4.31 |
Indraprastha Medical Corp | Moderately Bearish | 381.80 | -3.28 | 3,500.46 | 28.88 | 7.54 | 1.14 | 6.75 |
Artemis Medicare Services | Moderately Bearish | 258.55 | -1.17 | 3,545.33 | 74.21 | 7.91 | 0.17 | 63.85 |
Meeting Date | Purpose |
---|---|
2025-01-23 | Quarterly Results |
2024-10-23 | Quarterly Results |
2024-07-23 | Quarterly Results |
2024-05-14 | Audited Results & Final Dividend |
2024-02-01 | Quarterly Results |
Thyrocare Technologies is trading at 717.50 as on Mon Feb 17 2025 09:59:16. This is -0.61% lower as compared to its previous closing price of 721.90.
The market capitalization of Thyrocare Technologies is 3801.77 Cr as on Mon Feb 17 2025 09:59:16.
The average broker rating on Thyrocare Technologies is Buy. The breakup of analyst rating is given below -
The 52 wk high for Thyrocare Technologies is 1053.05 whereas the 52 wk low is 555.85
Thyrocare Technologies can be analyzed on the following key metrics -
Thyrocare Technologies reported a net profit of 70.76 Cr in 2024.
The Mutual Fund Shareholding was 12.75% at the end of 31 Dec 2024.